AstraZeneca

Senior Medical Director, Kidney Disease, Early Clinical Development CVRM

AstraZeneca$288K — $432K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • MD, MBBS or MD/PhD with expertise in kidney disease treatment.
  • 5+ years of clinical research experience in academia/pharmaceuticals.
  • Expertise in early clinical and translational trial design and execution.
  • Strong knowledge of biomarkers, surrogate endpoints, and biostatistics.
  • Excellent interpersonal skills with a track record of effective teamwork.

Responsibilities

  • Lead Phase I-II global trials focused on kidney disease, ensuring safety and compliance.
  • Provide clinical leadership to teams, integrating preclinical insights into clinical plans.
  • Contribute to regulatory documentation and interactions for clinical trials.
  • Advance development of nonclinical and surrogate endpoints through innovation.
  • Represent the organization externally through scientific engagements.
  • Evolve trial operations to enhance quality and inclusivity in studies.
  • Collaborate on programs intersecting kidney disease with heart failure, diabetes, and obesity.

Benefits

  • 401(k) retirement plan participation.
  • Paid vacation and holidays.
  • Paid leave benefits.
  • Health coverage including medical, dental, and vision.
Full Job Description
Location: Gaithersburg, MD

Hybrid: 3 days a week onsite

The Senior Medical Director will be focused on Kidney Disease and related conditions that impact kidney functionIn this role, you will have the opportunity to work at the forefront of early clinical and translational research within CVRM. In a multidisciplinary environment, you will play a key role in progressing a rich and diverse pipeline of both small and large molecules in numerous active clinical programs.

What You Will Do

You will be responsible for managing and leading to early phase I-II global clinical trials and related clinical research projects for compounds that are targeting kidney disease, as well as serving as an expert on the design, conduct, monitoring, data interpretation, and reporting of these studies.

Additionally, you will work on cross-functional teams within our TSCD group and across the broader global CVRM organization that are framing our strategies and development plans for compounds that are targeting cardiovascular diseases such as Heart Failure, as well as major metabolic disorders, such as Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis, given that these disorders intersect with chronic kidney disease and influence disease progression.

Responsibilities include:
  • Lead early Phase I-II global trials in kidney disease: clinical strategy, protocol design, study conduct, monitoring, data interpretation, and reporting, ensuring scientific integrity, patient safety, and regulatory compliance.
  • Provide clinical leadership to cross-functional teams; integrate preclinical insights (target selection, pharmacology, in vivo/in vitro data) into early clinical plans and seamless transitions to late phase development.
  • Contribute to regulatory interactions and documentation (e.g., CTAs, INDs, safety updates, annual reports).
  • Advance the development and validation of nonclinical and surrogate endpoints (including imaging and biomarkers).
  • Represent TSCD internally and externally through presentations, publications, and scientific forums; engage with external experts and translate insights into strategy and study design.
  • Help evolve trial operations and site engagement to improve speed, quality, and inclusivity in early studies.
  • Collaborate across CVRM on programs in heart failure, type 2 diabetes, obesity, and metabolic dysfunction-associated steatohepatitis, given their intersection with kidney disease.


For this role:
  • MD, MBBS or MD/PhD with established clinical or research expertise in the treatment of kidney diseases.
  • More than 5 years of clinical research in academia and/or the pharmaceutical/biotechnology industry.
  • Experience designing, executing, monitoring, interpreting, and overseeing safety in early clinical and translational trials preferred.
  • Strong command of biomarkers, surrogate endpoints, and biostatistics, supported by a robust publication record.
  • Well developed interpersonal skills, effective teamwork, and the ability to engage stakeholders effectively across functions, geographies, and disciplines.


The annual base pay for this position ranges from $288,059.20 - $432,088.80 USD Annual USD Annual USD Annual and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program. Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an "at-will position" and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.

Are you ready to be part of a talented, cross-functional team working together to improve lives and make the biggest possible impact for patients, science and society?

Apply now!

Date Posted
20-Jul-2026

Closing Date
20-Aug-2026

About AstraZeneca

AstraZeneca is a British-Swedish multinational pharmaceutical company that specializes in the research, development, and manufacturing of prescription drugs. The company was formed in 1999 through the merger of Astra AB and Zeneca Group plc. AstraZeneca's products are used to treat a wide range of medical conditions, including cancer, cardiovascular disease, respiratory disease, and diabetes. The company has operations in over 100 countries and employs more than 76,000 people worldwide. AstraZeneca is committed to developing innovative medicines that improve the health and well-being of people around the world.
Learn more about AstraZeneca
Size
83,100 employees
Market Cap
$211.5 billion
Industry
Net Income
$3.1 billion
Founded
1999
5 Year Trend
+10.2%
Revenue
$26.6 billion
NASDAQ

Similar Jobs

More Jobs at AstraZeneca

More Pharmaceuticals & Biotech Jobs

Find similar Senior Medical Director, Kidney Disease, Early Clinical Development CVRM jobs: